⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8092780 | 0.80 | — | — | |
| SCHEMBL3575455 | 0.74 | — | — | |
| SCHEMBL6270521 | 0.71 | KDM4E (0.33) | — | |
| SCHEMBL7491148 | 0.63 | — | — | |
| SCHEMBL9098522 | 0.61 | — | — | |
| SCHEMBL127131 | 0.59 | — | — | |
| SCHEMBL152294 | 0.59 | — | — | |
| SCHEMBL8441348 | 0.59 | — | — | |
| SCHEMBL11696210 | 0.59 | — | — | |
| SCHEMBL31128745 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065057-A2 | Chelating conjugates having a substituted aromatic moiety and derivatives thereof | Mallinckrodt Inc. (US) | 2009-06-03 | — | — | EP | claimed |
| US-20090053137-A1 | Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof | SpecGx LLC | 2009-02-26 | — | — | US | claimed |
| EP-1993613-A2 | CHELATING CONJUGATES HAVING A SUBSTITUTED AROMATIC MOIETY AND DERIVATIVES THEREOF | Mallinckrodt, Inc. (US) | 2008-11-26 | — | — | EP | claimed |
| WO-2007106544-A2 | CHELATING CONJUGATES HAVING A SUBSTITUTED AROMATIC MOIETY AND DERIVATIVES THEREOF | MALLINCKRODT INC. (US) | 2007-09-20 | — | — | WO | claimed |
| EP-0939844-B1 | PAPER PRODUCTION PROCESS | CLARIANT FINANCE BVI LTD (VG) | 2005-11-30 | — | — | EP | claimed |
| US-6267844-B1 | REDUCING BRIGHTNESS | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-07-31 | — | — | US | claimed |
| EP-0939844-A1 | PAPER PRODUCTION PROCESS | Clariant Finance (BVI) Limited (VG) | 1999-09-08 | — | — | EP | claimed |
| WO-1999011864-A1 | PAPER PRODUCTION PROCESS | CLARIANT FINANCE (BVI) LIMITED (VG) | 1999-03-11 | — | — | WO | claimed |
| EP-0358152-A1 | Diazine-substituted 1-adamantanes, process for their preparation, and their use as medicaments | Hess, Ulrich, Dr. (DE) | 1990-03-14 | — | — | EP | claimed |
| US-4415566-A | ANTIBIOTICS; BACTERIOSTATS; BACTERICIDES | BOEHRINGER INGELHEIM GMBH (DE) | 1983-11-15 | — | — | US | claimed |
| EP-0022494-B1 | BETA-LACTAM-COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1983-02-23 | — | — | EP | claimed |
| EP-0022494-A1 | Beta-lactam-compounds, process for their preparation and therapeutic agents containing them | Dr. Karl Thomae GmbH (DE) | 1981-01-21 | — | — | EP | claimed |
| US-9217009-B2 | Version of FDG detectable by single-photon emission computed tomography | MALLINCKRODT LLC (US) | 2015-12-22 | — | — | US | disclosed |
| US-20140378677-A1 | VERSION OF FDG DETECTABLE BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY | MALLINCKRODT VETERINARY, INC. | 2014-12-25 | — | — | US | disclosed |
| US-8858916-B2 | Metal chelate linked to a hexose carrier for use as a metallopharmaceutical diagnostic or therapeutic agent | MALLINCKRODT LLC (US) | 2014-10-14 | — | — | US | disclosed |
| US-20110177004-A1 | Version of FDG Detectable by Single-Photon Emission Computed Tomography | OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.) | 2011-07-21 | — | — | US | disclosed |
| US-4415566-A | ANTIBIOTICS; BACTERIOSTATS; BACTERICIDES | BOEHRINGER INGELHEIM GMBH (DE) | 1983-11-15 | — | — | US | disclosed |
| US-4399131-A | Cephem derivatives | HOECHST AG (DE) | 1983-08-16 | — | — | US | disclosed |
| US-4278793-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
| EP-0022494-A1 | Beta-lactam-compounds, process for their preparation and therapeutic agents containing them | Dr. Karl Thomae GmbH (DE) | 1981-01-21 | — | — | EP | disclosed |